Jiang, H
Acharya, C
An, G
Zhong, M
Feng, X
Wang, L
Dasilva, N
Song, Z
Yang, G
Adrian, F
Qiu, L
Richardson, P
Munshi, N C
Tai, Y-T
Anderson, K C
Article History
Received: 18 May 2015
Revised: 20 August 2015
Accepted: 21 August 2015
First Online: 4 September 2015
Competing interests
: ZS, GY and FA are employees of Sanofi whose product was used in this research. Y-TT is a consultant for Onyx. PR serves on advisory boards to Millennium, Celgene, Novartis, Johnson & Johnson and Bristol-Myers Squibb. NCM serves on advisory boards to Millennium, Celgene and Novartis. KCA serves on advisory boards to Onyx, Celgene, Gilead, Bristol-Myers Squibb and Sanofi-Aventis and is a scientific founder of Acetylon and Oncopep. The remaining authors declare no competing financial interest.